Skip to main content
INFUND HOLDING CO.，LTD logo

INFUND HOLDING CO.，LTD — Investor Relations & Filings

Ticker · 002141 ISIN · CNE1000005S1 Shenzhen Stock Exchange Financial and insurance activities
Open in API
Filings indexed 2,290 across all filing types
Latest filing 2021-11-01 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 002141

About INFUND HOLDING CO.，LTD

https://www.sz002141.com

INFUND HOLDING CO., LTD. is a multi-sector enterprise group that manages a diverse portfolio across biotechnology, real estate development, and financial services. The organization specializes in life sciences, particularly in the areas of stem cell technology, genetic engineering, and human cryopreservation. Its real estate operations encompass the planning, construction, and management of residential and commercial properties. Furthermore, the company maintains a significant presence in the financial sector through strategic investments, asset management, and capital operations. The firm focuses on the integration of scientific innovation with industrial development to provide specialized services in healthcare and urban infrastructure.

Recent filings

Filing Released Lang Actions
董事会关于本次交易履行法定程序完备性、合规性及提交的法律文件的有效性的说明
Capital/Financing Update Classification · 95% confidence The document is a statement from the board of directors of 贤丰控股股份有限公司 regarding the completeness, compliance, and validity of legal documents submitted for a major asset sale transaction. It discusses the legal procedures followed, regulatory compliance, and upcoming required approvals related to a significant asset disposal. The content focuses on the procedural and legal aspects of a major asset restructuring rather than presenting financial data or results. It is not an annual report, earnings release, or audit report. It is also not a proxy solicitation or voting result announcement. The document is a formal board statement about a major asset sale transaction and its compliance with legal requirements, which fits best under the category of Capital/Financing Update (CAP) as it relates to significant financing and asset restructuring activities. The document length is 2040 characters, which is too long for a simple announcement but does not contain financial statements or detailed financial analysis, so it is not an interim or annual report. Therefore, the best classification is CAP with high confidence.
2021-11-01 Chinese
董事会关于本次交易符合《关于规范上市公司重大资产重组若干问题的规定》第四条规定的说明
M&A Activity Classification · 95% confidence The document is a formal statement from the board of directors of 贤丰控股股份有限公司 regarding a significant asset sale transaction. It references compliance with regulations on major asset restructurings for listed companies, specifically citing the relevant regulatory provisions. The content focuses on explaining how the transaction meets regulatory requirements and the strategic rationale behind the asset sale. There is no financial data, no earnings or annual report content, no voting results, no management changes, and no presentation or transcript format. The document is an announcement related to a major asset restructuring transaction, which aligns with the category for M&A Activity (TAR) filings that cover merger proposals or takeover bids and related asset transactions. The document length is short (1182 characters), but it is not merely announcing the publication of a report; it contains substantive explanation about the transaction itself. Therefore, the best classification is M&A Activity (TAR).
2021-11-01 Chinese
第七届董事会第十一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 11th meeting of the 7th Board of Directors of Xianfeng Holdings Co., Ltd. It includes multiple agenda items related to a major asset sale, compliance with relevant laws and regulations, and preparations for shareholder approval. The content focuses on board decisions, voting results, and procedural compliance rather than financial results or earnings. There is no indication that this is a full annual or interim report, audit report, or earnings release. The document is not a transcript, presentation, or dividend notice. It clearly relates to board-level decisions and management information about a significant transaction. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length (6784 characters) and detailed content support this classification with high confidence.
2021-11-01 Chinese
独立董事关于公司重大资产出售事项的事前认可意见
Regulatory Filings Classification · 95% confidence The document is a formal opinion from independent directors regarding a major asset sale by the company. It references compliance with company law, securities law, and regulations on major asset restructurings. The document is a pre-approval or endorsement opinion for a significant transaction to be considered by the board. It does not contain financial statements or detailed financial data, nor is it a report or announcement of voting results. It is a regulatory compliance and governance-related document focused on a major asset sale transaction. This fits best under the category of Regulatory Filings (RNS), as it is a formal regulatory disclosure related to a corporate transaction but not a full report or announcement type covered by other categories.
2021-11-01 Chinese
贤丰控股重大资产出售预案摘要
Capital/Financing Update Classification · 95% confidence The document is a detailed summary of a major asset sale plan by Xianfeng Holdings Co., Ltd. It includes extensive information about the transaction parties, asset valuation, impact on the company, legal and regulatory compliance, and various commitments and assurances by the company and its controlling shareholders. The document discusses the transaction as a major asset restructuring but explicitly states it is not a re-listing or related to share issuance. It contains no financial statements or quarterly/yearly financial results but focuses on the transaction details, approvals, and governance implications. This matches the definition of a Capital/Financing Update (CAP) as it provides updates on a significant financing activity (major asset sale and restructuring). The document length and content indicate it is not a mere announcement but a substantive update on the capital transaction.
2021-11-01 Chinese
董事会关于本次交易符合《上市公司重大资产重组管理办法》第十一条规定的说明
Regulatory Filings Classification · 95% confidence The document is a formal statement from the board of directors of 贤丰控股股份有限公司 regarding the compliance of a specific transaction with Article 11 of the "Administrative Measures for Major Asset Restructuring of Listed Companies". It details the transaction of selling a significant equity stake in a subsidiary and confirms that the transaction meets regulatory requirements, including legal, financial, and governance aspects. The document is not a full financial report, audit, or earnings release, nor is it a voting result or management change announcement. It is a compliance explanation related to a major asset restructuring transaction. Such documents typically fall under Regulatory Filings (RNS) as they are regulatory compliance disclosures that do not fit other specific categories like M&A filings or capital updates. The document length is 2342 characters, relatively short and focused on regulatory compliance explanation rather than a full report or announcement of a report publication.
2021-11-01 Chinese

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.